Skip to main content

Table 1 Descriptive statistics

From: Elevated levels of anti inflammatory IL-10 and pro inflammatory IL-17 in malignant pleural effusions

  N Minimum Maximum Mean Std. Deviation
IL- 17 B 24 18.258 31.605 23.63281 3.553243
IL-10 B 24 .00 112.43 13.8533 28.72131
IL-17 P 24 21.009 33.020 24.97380 3.595384
IL-10 P 24 1.75 229.83 60.1112 59.13965
WBC 24 2.3 30.6 10.296 5.5273
RBC 24 3.16 5.17 3.9788 .53680
HCT 24 28.4 46.5 36.192 4.7277
PLT 24 87 658 283.71 117.411
HB 24 9 16 12.02 1.675
GR% 24 43.5 93.8 71.912 10.7272
MONO% 24 .8 30.6 9.846 6.6490
LYMPH% 24 1.4 32.1 17.308 7.5535
AGE 24 37 74 60.42 10.270
GENDER 24 1 2 1.63 .495
AGEgroup 24 1 3 2.50 .659
primary1 24 1 2 1.63 .495
TYPE_3_UN 24 1 3 2.04 .624
chemo1yes 24 0 1 .58 .504
Valid N (listwise) 24     
  1. IL-17B Interleukin 17 levels in Blood, IL-10B Interleukin 10 levels in Blood, IL-17P Interleukin 17 levels in Pleural Fluid, IL-10P Interleukin 10 levels in Pleural Fluid, WBC White Blood Cells Count, RBC Red Blood Cells Count, HCT Heamatocrit, PLT Platelets, HB Heamoglobulin, GR% Granulocytes percentage, MONO% Monocytes percentage, LYMPH% Lymphocytes percentage, AGE Age, GENDER Gender, AGEgroup 1 = age 1 to 39, 2 = 40 to 59, 3 = 60 and above, Primary1 1 = Lung cancer, 2 = other, TYPE_3_UN 1 = NSCLC,SCLC,AdenoCa Lung/2 = other malignancy/3 = Unknown origin of malignancy, chemo1yes chemotherapy done = 1.